MH
Mark Hopman sold $681K of BBNX stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 36,870 shares of BBNX stock worth $681K, per an SEC Form 4 filed Sep 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 9, 2026, 1 day before it was made public.
BBNX has moved -23.5% since the trade date, from $17.42 to $13.32 (Nov 19, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 1 day
- Price since
- -23.5%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4